CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.

sodium valproate delayed release (CS1) - Cereno Scientific

sodium valproate - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/38174159

Björn Dahlöf; Deepak L Bhatt; Fredrik Frick; Gunnar Olsson; Niklas Bergh; Philip B Adamson; Raymond L Benza

Jan 4, 2024